Skip to main content
SpringerLink
Log in
Book cover

Clinical Nuclear Medicine pp 53–63Cite as

Lymphoma

  • Chapter

  • 136 Accesses

Abstract

Lymphomas include Hodgkin lymphoma (HL) and non-Hodgkin lymphoma (NHL). Both types of lymphoma have multiple and complex methods of grading that are beyond the scope of this text but are reviewed elsewhere [1]. The diseases have a global presence, though prevalence of B- versus T-cell types of NHL vary geographically. In the United States, more than 80% of NHL are of B-cell origin, while the rest are of T-cell origin.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Longo, D.L., Mauch, P., DeVita, V.T., Urba, W.J. et al. (1993) Lymphocytic Lymphomas (eds V.T. DeVita, S. Hellman and S.A. Rosenberg), Can. Principles Practice of Oncology, Lippincott, Philadelphia, PA, pp. 1859–927.

    Google Scholar 

  2. Shea, R. and Wahl, R.L. (1995) Oncology: Lymphoma, in Principles of Nuclear Medicine, 2nd edn (eds H.N. Wagner, Jr, Z. Szabo and J.W. Buchanan), Philadelphia, PA, pp. 1111–17.

    Google Scholar 

  3. Grossbard, M.L. and Nadler, L.M. (1993) Monoclonal antibody therapy for indolent lymphomas. Semin. Oncol., 20(5), 118–35.

    PubMed  CAS  Google Scholar 

  4. Kaminski, M.S., Zasadny, K.R., Francis, LR. et al. (1996) Iodine-131-Anti-Bl radioimmunotherapy for B-cell lymphoma. J. Clin. Oncol., 14(7), 1974–81.

    PubMed  CAS  Google Scholar 

  5. Mello, A.M., Pauwels, E.K.J, and Cleton, F.J. (1994) Radioimmunotherapy: No news from the newcomer. J. Can. Res. Clin. Oncol., 120, 121–30.

    Article  CAS  Google Scholar 

  6. Beierwaltes (personal communication).

    Google Scholar 

  7. Ghose, T. and Guclu, A. (1974) Cure of a mouse lymphoma with radio-iodinated antibody. Eur. J. Cancer, 10(12), 787–92.

    PubMed  CAS  Google Scholar 

  8. Kohler, G. and Milstein, C (1975) Continuous cultures of fused cells secreting antibody of predefined specificity. Nature, 256, 495–7.

    Article  PubMed  CAS  Google Scholar 

  9. Jurcic, J.G., Caron, P.C. and Scheinberg, D.A. (1995) Monoclonal antibody therapy of leukaemia and lymphoma. Adv. Pharmacol, 33, 287–314.

    Article  PubMed  CAS  Google Scholar 

  10. White, CA., Halpern, S.E., Parker, B.A. et al. (1996) Radioimmunotherapy of relapsed B-cell lymphoma with yttrium-90 anti-idiotype monoclonal antibodies. Blood, 87(9), 3640–9.

    PubMed  CAS  Google Scholar 

  11. Press, O.W., Appelbaum, F.R., Eary, J.F. and Bernstein, I.D. (1995) Radiolabelled antibody therapy of lymphomas. Important Adv. Oncol., 157–71.

    Google Scholar 

  12. Wilder, R.B., DeNardo, G.L. and DeNardo, S.J. (1996) Radioimmunotherapy: recent results and future directions. J. Clin. Oncol., 14(4), 1383–400.

    PubMed  CAS  Google Scholar 

  13. Zalutsky, M.R. and Bigner, D.D. (1996) Radioimmunotherapy with x-particle emitting radio-immunoconjugates. Acta Oncol., 35(3), 373–9.

    Article  PubMed  CAS  Google Scholar 

  14. Lenhard, R.E., Order, S.E., Spunberg, J.J. et al. (1985) Isotopic immunoglobulin. A new systemic therapy for advanced Hodgkin’s disease. J. Clin. Oncol., 3, 1296–300.

    PubMed  Google Scholar 

  15. Herpst, J.M., Klein, J.L., Leichner, P.K., Quadri, S.M. and Vriesendorp, H.M. (1995) Survival of patients with resistant Hodgkin’s disease after polyclonal yttrium-90 labeled antiferritin treatment. J. Clin. Oncol., 13(9), 2394–400.

    PubMed  CAS  Google Scholar 

  16. Bierman, P.J., Vose, J.M., Leichner, P.K. et al. (1993) Yttrium-90 labeled antiferritin followed by high-dose chemotherapy and autologous bone marrow transplantation for poor-prognosis Hodgkin’s disease. J. Clin. Oncol., 11(4), 698–703.

    PubMed  CAS  Google Scholar 

  17. Rosen, S.T., Zimmer, A.M., Goldman-Leikin, R. et al. (1987) Radioimmunodetection and radioimmunotherapy of cutaneous T cell lymphomas using an 131I-labeled monoclonal antibody: an Illinois Cancer Council Study. J. Clin. Oncol., 5(4), 562–73.

    PubMed  CAS  Google Scholar 

  18. Kaplan, E.H., Goldman-Leikin, R.E., Radosevich, J.A. et al. (1989) Cancer and Aging; Progress in Research and Treatment (eds T.V. Zenser and R.M. Coe), Springer Publishing, New York, pp. 86–109.

    Google Scholar 

  19. Waldmann, T.A., White, J.D., Carrasquillo, J.A. et al. (1995) Radioimmunotherapy of interleukin-2R alpha-expressing adult T-cell leukaemia with Yttrium-90-labeled anti-Tac. Blood, 86(11), 4063–75.

    PubMed  CAS  Google Scholar 

  20. Lewis, J.P., DeNardo, G.L. and DeNardo, S.J. (1995) Radioimmunotherapy of Lymphoma: A UC Davis Experience. Hybridoma, 14(2), 115–20.

    Article  PubMed  CAS  Google Scholar 

  21. Kaminski, M.S., Fig, L.M., Zasadny, K.R. et al. (1992) Imaging, dosimetry, and radioimmunotherapy with iodine-131-labeled anti-CD37 antibody in B-cell lymphoma. J. Clin. Oncol., 10(11), 1696–711.

    PubMed  CAS  Google Scholar 

  22. Czuczman, M.S., Straus, D.J., Divgi, CR. et al. (1993) Phase I dose-escalation trial of iodine-131-labeled monoclonal antibody OKB7 in patients with non-Hodgkin’s lymphoma. J. Clin. Oncol., 11(10), 2021–9.

    PubMed  CAS  Google Scholar 

  23. Knox, S.J., Goris, M.L., Trisler, K. et al. (1996) Yttrium-90 labeled anti-CD20 monoclonal antibody therapy of recurrent B-cell lymphoma. Clin. Cancer Res., 2, 457–70.

    PubMed  CAS  Google Scholar 

  24. Goldenberg, D.M., Horowitz, J.A., Sharkey, R.M. et al. (1991) Targeting, dosimetry, and radioimmunotherapy of B-cell lymphomas with iodine-131-labeled LL2 monoclonal antibody. J. Clin. Oncol., 9(4), 548–64

    PubMed  CAS  Google Scholar 

  25. Juweid, M., Sharkey, R.M., Markowitz, A. et al. (1995) Treatment of non-Hodgkin’s lymphoma with radiolabeled murine, chimeric, or humanized LL2, an anti-CD22 monoclonal antibody. Cancer Res. Ctr, 55, 5899–907.

    Google Scholar 

  26. Press, O.W., Eary, J.F., Appelbaum, F.R. et al. (1993) Radiolabeled-antibody tnerapy of B-cell lymphoma with autologous bone marrow support. N. Engl. J. Med., 329(17), 1219–24

    Article  PubMed  CAS  Google Scholar 

  27. Press, O.W., Eary, J.F., Appelbaum, F.R. et al. (1995) Phase II trial of 131I-B1 (anti-CD20) antibody therapy with autologous stem cell transplantation for relapsed B cell lymphomas. Lancet, 346, 336–40.

    Article  PubMed  CAS  Google Scholar 

  28. Eary, J.F. and Press, O.W. (1996) High dose radioimmunotherapy in malignant lymphoma. Rec. Res. Cancer Res., 141, 177–82

    Article  CAS  Google Scholar 

  29. Macey, D.J., DeNardo, S.J., DeNardo, G.L. et al. (1995) Estimation of radiation absorbed doses to the red marrow in radioimmunotherapy. Clin. Nucl. Med., 20(2), 117–25.

    Article  PubMed  CAS  Google Scholar 

  30. Juweid, M., Sharkey, R.M., Siegel, J.A. et al. (1995) Estimates of red marrow dose by sacral scintigraphy in radioimmunotherapy patients having non-Hodgkin’s lymphoma and diffuse bone marrow uptake. Cancer Res. (Suppl.), 55, 5827–31.

    Google Scholar 

  31. Zasadny, K.R. and Wahl, R.L. (1996) A simplified method for determining therapeutic activity to administer for radioimmunotherapy. The Society of Nuclear Medicine 43rd Annual Meeting, Denver, CO, June 3–5, 1996. J. Nucl. Med., 37(5), 43P.

    Google Scholar 

  32. Macklis, R.M., Beresford, B.A., Palayoor, S. et al. (1993) Cell cycle alterations, apoptosis, and response to low-dose-rate radioimmunotherapy in lymphoma cells. Radiat. Oncol., 27, 643–50.

    CAS  Google Scholar 

Download references

Authors
  1. R. L. Wahl
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Division of Radiological Sciences, Guy’s and St Thomas’ Hospital, London, UK

    M. N. Maisey BSc MD FRCR FRCP

  2. Department of Nuclear Medicine, St Bartholomew’s Hospital, London, UK

    K. E. Britton MD MSc FRCR FRCP

  3. Nuclear Medicine Department, Medical College of Wisconsin, Milwaukee, Wisconsin, USA

    B. D. Collier BA MA MD

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Wahl, R.L. (1998). Lymphoma. In: Maisey, M.N., Britton, K.E., Collier, B.D. (eds) Clinical Nuclear Medicine. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-3356-0_6

Download citation

  • DOI: https://doi.org/10.1007/978-1-4899-3356-0_6

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-0-412-75180-6

  • Online ISBN: 978-1-4899-3356-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation